X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES ORCHID PHARMA LTD JUBILANT LIFE SCIENCES/
ORCHID PHARMA LTD
 
P/E (TTM) x 13.0 -0.2 - View Chart
P/BV x 1.8 0.1 1,461.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-18
ORCHID PHARMA LTD
Sep-13
JUBILANT LIFE SCIENCES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,039194 535.6%   
Low Rs60035 1,714.3%   
Sales per share (Unadj.) Rs482.6276.5 174.5%  
Earnings per share (Unadj.) Rs40.7-79.2 -51.4%  
Cash flow per share (Unadj.) Rs67.4-43.5 -155.0%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs262.353.9 486.3%  
Shares outstanding (eoy) m155.7970.45 221.1%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.70.4 410.0%   
Avg P/E ratio x20.1-1.4 -1,392.1%  
P/CF ratio (eoy) x12.2-2.6 -461.6%  
Price / Book Value ratio x3.12.1 147.2%  
Dividend payout %7.40-   
Avg Mkt Cap Rs m127,6708,067 1,582.7%   
No. of employees `0002.42.8 87.0%   
Total wages/salary Rs m15,5592,527 615.7%   
Avg. sales/employee Rs Th30,861.46,956.1 443.7%   
Avg. wages/employee Rs Th6,387.0902.5 707.7%   
Avg. net profit/employee Rs Th2,604.4-1,993.0 -130.7%   
INCOME DATA
Net Sales Rs m75,17819,477 386.0%  
Other income Rs m400407 98.3%   
Total revenues Rs m75,57919,884 380.1%   
Gross profit Rs m15,1841,103 1,377.1%  
Depreciation Rs m4,1512,519 164.8%   
Interest Rs m2,8435,227 54.4%   
Profit before tax Rs m8,591-6,236 -137.8%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m2,247-125 -1,794.4%   
Profit after tax Rs m6,344-5,580 -113.7%  
Gross profit margin %20.25.7 356.8%  
Effective tax rate %26.22.0 1,302.6%   
Net profit margin %8.4-28.7 -29.5%  
BALANCE SHEET DATA
Current assets Rs m31,89811,014 289.6%   
Current liabilities Rs m20,04732,060 62.5%   
Net working cap to sales %15.8-108.1 -14.6%  
Current ratio x1.60.3 463.2%  
Inventory Days Days6895 71.2%  
Debtors Days Days5534 163.6%  
Net fixed assets Rs m60,71529,440 206.2%   
Share capital Rs m156705 22.1%   
"Free" reserves Rs m40,7102,043 1,993.0%   
Net worth Rs m40,8653,800 1,075.4%   
Long term debt Rs m30,4789,018 338.0%   
Total assets Rs m96,17646,510 206.8%  
Interest coverage x4.0-0.2 -2,082.6%   
Debt to equity ratio x0.72.4 31.4%  
Sales to assets ratio x0.80.4 186.7%   
Return on assets %9.6-0.8 -1,256.8%  
Return on equity %15.5-146.9 -10.6%  
Return on capital %16.0-3.7 -429.1%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m14,4027,513 191.7%   
Fx outflow Rs m12,0445,649 213.2%   
Net fx Rs m2,3581,865 126.5%   
CASH FLOW
From Operations Rs m13,0321,682 774.9%  
From Investments Rs m-6,177-9,860 62.6%  
From Financial Activity Rs m-9,0116,644 -135.6%  
Net Cashflow Rs m-2,123-1,535 138.3%  

Share Holding

Indian Promoters % 45.6 32.3 141.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.6 189.1%  
FIIs % 21.2 3.3 642.4%  
ADR/GDR % 0.0 4.6 -  
Free float % 21.1 55.3 38.2%  
Shareholders   23,815 84,811 28.1%  
Pledged promoter(s) holding % 15.9 54.9 28.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 491 Points Lower; Metal and Energy Stocks Witness Selling(Closing)

After opening the day marginally lower, share markets in India witnessed negative trading activity throughout the day and ended deep in the red.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 17, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS